Zevra Therapeutics (ZVRA) Amortization - Intangibles (2014 - 2026)
Zevra Therapeutics' Amortization - Intangibles came in at $315,000 for Q3 2026, unchanged from $315,000 a year earlier and down 0.3% from the prior quarter.
Powered by 
Analysis
Zevra Therapeutics (ZVRA) Amortization - Intangibles (2014 - 2026) Analysis & Trends
Over the trailing twelve months to Sep 30, 2026, Zevra Therapeutics reported Amortization - Intangibles of $1.26 million, down 75.5% year-over-year; for FY2025, it was $3.86 million, down 38.1% from FY2024.
- Going back by year, Amortization - Intangibles was $6.24 million in FY2024 (+707.6%) and $772,000 in FY2023.
- The five-year range for quarterly Amortization - Intangibles is $315,000 (Q3 2025) to $1.62 million (Q2 2025).
- Year-over-year, Amortization - Intangibles increased in three of the last eight quarters, with an average decline of 25.2%.
- The fastest year-over-year change in Amortization - Intangibles over five years came in Q4 2024 (growth of 109.3%), and the weakest in Q4 2025 (a decline of 80.4%).
- Business Quant data shows ZVRA's Amortization - Intangibles at $316,000 (Q2 2026), $316,000 (Q1 2026) and $316,000 (Q4 2025) in the three quarters before Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Zevra Therapeutics | 708.52 Mn | -100.24 Mn | 36.01 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 315,000.00 |
| Jun 30, 2026 | 316,000.00 |
| Mar 31, 2026 | 316,000.00 |
| Dec 31, 2025 | 316,000.00 |
| Sep 30, 2025 | 315,000.00 |
| Jun 30, 2025 | 1.62 Mn |
| Mar 31, 2025 | 1.62 Mn |
| Dec 31, 2024 | 1.62 Mn |
| Sep 30, 2024 | 1.55 Mn |
| Jun 30, 2024 | 1.55 Mn |
| Mar 31, 2024 | 1.53 Mn |
| Dec 31, 2023 | 772,000.00 |
| Sep 30, 2015 | -479,000.00 |
| Jun 30, 2015 | -477,000.00 |
| Mar 31, 2015 | -477,000.00 |
| Dec 31, 2014 | -478,000.00 |
| Sep 30, 2014 | -477,000.00 |
| Jun 30, 2014 | -159,000.00 |
API Access
Zevra Therapeutics Amortization - Intangibles API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=amortization-intangibles&ticker=ZVRA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "amortization-intangibles", "ticker": "ZVRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=amortization-intangibles&ticker=ZVRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();